DCF — BAYSHORE MEDICAL CENTER
Enterprise Value: $4.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$4.4M
Enterprise Value
$-3.6M
PV of Cash Flows
$8.0M
PV of Terminal Value
$12.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $192.3M | $5.1M | 3.0% | $-3.1M | $-2.8M |
| Year 2 | $198.1M | $7.2M | 4.0% | $-1.7M | $-1.4M |
| Year 3 | $204.0M | $9.5M | 5.0% | $-0.3M | $-0.2M |
| Year 4 | $210.1M | $10.8M | 5.0% | $0.5M | $0.4M |
| Year 5 | $216.4M | $11.7M | 5.0% | $0.9M | $0.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $4.4M. Terminal value accounts for 181% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$186.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.02137904775012685
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5